华北制药(600812.SH)：第三季度净利润3500.6万元，同比增长14.85%

Core Viewpoint - North China Pharmaceutical (600812.SH) reported a decline in revenue for the third quarter, while net profit showed an increase year-on-year, indicating mixed financial performance [1] Financial Performance - The company achieved an operating revenue of 2.21 billion yuan in the third quarter, representing a year-on-year decrease of 5.12% [1] - The net profit attributable to shareholders was 35.006 million yuan, reflecting a year-on-year increase of 14.85% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 23.378 million yuan, which is a year-on-year decrease of 17.12% [1] - Basic earnings per share were reported at 0.020 yuan [1]